Panama
CureVac doses first subject in Phase I influenza vaccine trial
Set to be carried out in Panama, the trial is anticipated to enrol up to 240 healthy subjects.
Set to be carried out in Panama, the trial is anticipated to enrol up to 240 healthy subjects.